A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Beckman Symposium Bookmark and Share

The 25th Beckman Symposium - Microbiota in Health and Disease

Date
Friday, November 6, 2015
8 a.m. to 5:40 p.m.

Location
City of Hope
Cooper Auditorium
1500 E. Duarte Road
Duarte, CA 91010-3000

Overview
The 25th Beckman Symposium to be held at Beckman Research Institute of City of Hope. Supported by funds from the Beckman Endowment, the Beckman Symposia are arranged annually by the research staff organization of City of Hope.
 
 
2015 Speaker List:
 
Yasmine Belkaid, Ph.D.
National Institute of Allergy and Infectious Diseases, NIH
 
Ami S. Bhatt, M.D., Ph.D.
Stanford University
 
Elhanan Borenstein, Ph.D.
University of Washington
 
Ken Cadwell, Ph.D.
Skirball Institute, NYU School of Medicine
 
Eran Elinav, M.D., Ph.D.
Weizmann Institute of Science, Rehovot, Israel
 
Sarkis K. Mazmanian, Ph.D.
California Institute of Technology
 
Eric G. Pamer, M.D.
Memorial Sloan Kettering Cancer Center
 
Cynthia L. Sears, M.D.
Johns Hopkins University
 
Peter J. Turnbaugh, Ph.D.
University of California, San Francisco

 

In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the program coordinator listed above prior to the symposium. This advance notification will help us serve you better.

 

2015 Symposium Program

November 6, 2015
 
8 to 8:20 a.m.
Registration 

8:20 to 8:30 a.m.
Welcome
Steven Rosen, M.D.
Provost, City of Hope
Director, Beckman Research Institute

8:30 to 9:20 a.m.
Microbiota-mediated Defense against Intestinal Colonization by Antibiotic-resistant Pathogens
Eric G. Pamer, M.D., Memorial Sloan Kettering Cancer Center

9:20 to 10:10 a.m.
Discovery of a Potential Probiotic Therapy for Autism
Sarkis K. Mazmanian, Ph.D., California Institute of Technology

10:10 to 10:30 a.m.
Break

10:30 to 11:20 a.m.
Long-term Consequences of Host-Microbiota Interactions
Yasmine Belkaid, Ph.D., National Institute of Allergy and Infectious Diseases, NIH

11:20 a.m. to 12:10 p.m.
Frenemies in the Gut—Infectious Agents that Defy Classification
Ken Cadwell, Ph.D., Skirball Institute, NYU School of Medicine

12:10 to 1:10 p.m.
Lunch

1:10 to 2 p.m.
Biofilms, Genetics, and Colon Cancer
Cynthia L. Sears, M.D., Johns Hopkins University

2 to 2:50 p.m.
Bugs, Drugs, and Stem Cells
Ami S. Bhatt, M.D., Ph.D., Stanford University

2:50 to 3:40 p.m.
Systems Biology, Modeling, and Cross-meta-omic Analysis of the Human Microbiome
Elhanan Borenstein, Ph.D., University of Washington

3:40 to 4 p.m.
Break

4 to 4:50 p.m.
Host Microbiome Interactions in Health and Disease
Eran Elinav, M.D., Ph.D., Weizmann Institute of Science, Rehovot, Israel

4:50 to 5:40 p.m.
Predicting and Preventing Drug Metabolism by the Human Gut Microbiome
Peter J. Turnbaugh, Ph.D., University of California, San Francisco

Beckman Symposium

The 25th Beckman Symposium - Microbiota in Health and Disease

Date
Friday, November 6, 2015
8 a.m. to 5:40 p.m.

Location
City of Hope
Cooper Auditorium
1500 E. Duarte Road
Duarte, CA 91010-3000

Overview
The 25th Beckman Symposium to be held at Beckman Research Institute of City of Hope. Supported by funds from the Beckman Endowment, the Beckman Symposia are arranged annually by the research staff organization of City of Hope.
 
 
2015 Speaker List:
 
Yasmine Belkaid, Ph.D.
National Institute of Allergy and Infectious Diseases, NIH
 
Ami S. Bhatt, M.D., Ph.D.
Stanford University
 
Elhanan Borenstein, Ph.D.
University of Washington
 
Ken Cadwell, Ph.D.
Skirball Institute, NYU School of Medicine
 
Eran Elinav, M.D., Ph.D.
Weizmann Institute of Science, Rehovot, Israel
 
Sarkis K. Mazmanian, Ph.D.
California Institute of Technology
 
Eric G. Pamer, M.D.
Memorial Sloan Kettering Cancer Center
 
Cynthia L. Sears, M.D.
Johns Hopkins University
 
Peter J. Turnbaugh, Ph.D.
University of California, San Francisco

 

In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the program coordinator listed above prior to the symposium. This advance notification will help us serve you better.

 

Symposium Program

2015 Symposium Program

November 6, 2015
 
8 to 8:20 a.m.
Registration 

8:20 to 8:30 a.m.
Welcome
Steven Rosen, M.D.
Provost, City of Hope
Director, Beckman Research Institute

8:30 to 9:20 a.m.
Microbiota-mediated Defense against Intestinal Colonization by Antibiotic-resistant Pathogens
Eric G. Pamer, M.D., Memorial Sloan Kettering Cancer Center

9:20 to 10:10 a.m.
Discovery of a Potential Probiotic Therapy for Autism
Sarkis K. Mazmanian, Ph.D., California Institute of Technology

10:10 to 10:30 a.m.
Break

10:30 to 11:20 a.m.
Long-term Consequences of Host-Microbiota Interactions
Yasmine Belkaid, Ph.D., National Institute of Allergy and Infectious Diseases, NIH

11:20 a.m. to 12:10 p.m.
Frenemies in the Gut—Infectious Agents that Defy Classification
Ken Cadwell, Ph.D., Skirball Institute, NYU School of Medicine

12:10 to 1:10 p.m.
Lunch

1:10 to 2 p.m.
Biofilms, Genetics, and Colon Cancer
Cynthia L. Sears, M.D., Johns Hopkins University

2 to 2:50 p.m.
Bugs, Drugs, and Stem Cells
Ami S. Bhatt, M.D., Ph.D., Stanford University

2:50 to 3:40 p.m.
Systems Biology, Modeling, and Cross-meta-omic Analysis of the Human Microbiome
Elhanan Borenstein, Ph.D., University of Washington

3:40 to 4 p.m.
Break

4 to 4:50 p.m.
Host Microbiome Interactions in Health and Disease
Eran Elinav, M.D., Ph.D., Weizmann Institute of Science, Rehovot, Israel

4:50 to 5:40 p.m.
Predicting and Preventing Drug Metabolism by the Human Gut Microbiome
Peter J. Turnbaugh, Ph.D., University of California, San Francisco
Research Overview
City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.

Beckman Research Institute

Beckman Research Institute of City of Hope is internationally  recognized for its innovative translational biomedical research.
 

Comprehensive Cancer Center
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and education.

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Technology & Licensing
The Center for Applied Technology Development offers broad expertise in
technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 



NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...